Are you affected by
systemic sclerosis?

If you or a loved one are living with systemic sclerosis (scleroderma or SSc), consider joining the TibuSURE clinical study where researchers are exploring whether a new study drug could impact disease progression in individuals with systemic sclerosis.

I'm interested

What is the Purpose of the TibuSURE Study?

The goal of this study is to determine the safety and effectiveness of tibulizumab and determine whether it affects certain systemic sclerosis signs and symptoms.

You may know systemic sclerosis as scleroderma or SSc.
Click Here to Express Interest

Can I Participate?

You may be eligible to participate in this study if you:

I'm Interested

Are between 18 and 70 years old

Have a confirmed diagnosis of systemic sclerosis impacting your extremities (for example: arms, legs, hands, feet, etc.)

Have experienced symptoms related to your systemic sclerosis for fewer than 5 years (apart from Raynaud’s)

Why Should I Join the TibuSURE Study?

By enrolling in this Phase 2 study, you may participate in a clinical study working to determine if the study drug is able to decrease disease activity in the following ways:

Reduce skin thickening

Improve lung function

‍Other eligibility criteria apply and will be evaluated by a study doctor if you choose to continue with screening for the study.

I'm Interested
Uncertainty related to systemic sclerosis is hard; learning about your options shouldn't be.
Learn more about this clinical study opportunity.

By enrolling in this Phase 2 study, you may receive:

Access to expert physicians with experience managing systemic sclerosis

Travel and accommodation support for study visits

Assessments on your health

The investigational study drug at no cost to you

Insurance is not required to join this study

Click Here to Express Interest  
Learn More

What Should I Expect?

Step 1
Submit Online Questionnaire
This questionnaire will ask for your contact information and a few questions about your medical history to determine your eligibility. Then, select a time for a short phone call with PatientWing.

Submitting the questionnaire is voluntary and does not require a commitment to participate in the study.

Step 2
Speak With PatientWing
PatientWing is partnering with Zura Bio to help identify potential individuals who may be interested and qualify for the TibuSURE study.  You will have a short call to answer additional questions about your medical history and determine whether you might be a potential participant for the study. If appropriate, PatientWing will help collect your medical records. 
Step 3
Speak With a Research Site
After your conversation with PatientWing, you may meet the research team who will review your medical records.  If the research team thinks you are a good fit, they will schedule a screening visit. The research team will provide more information during your conversation with them.

No question is a bad question so please share your concerns with the team! 
Step 4
Study Participation
‍After you've completed the screening activities, the research team will notify you about your eligibility to continue as a study participant and potentially receive drug as part of the trial. If you continue in the study after being confirmed as eligible, you should expect the following:

• You will visit the study site 16 times over approximately 1 year and 2 months.
‍• You will be given 2 injections at the study site once every two weeks for the first month and then every four weeks thereafter.
• If eligible, you may receive travel and accommodation support for study visits.  

Frequently Asked Questions

How do I get started?

How often do I need to visit the research site?  

Is there any cost for me to participate?

How will the study drug be taken?

How long will the study take?

Are there possible benefits of participating?

Who's Involved?

Option Item Img
Our mission is to transform the lives of those living with severe autoimmune and inflammatory conditions by aiming to deliver breakthrough treatments that offer real hope and lasting impact.
Option Item Img
Our mission to bring better treatments to more people faster starts with you. We help sponsors find patients to participate in their clinical studies. With our focus on rare and serious conditions and expertise in navigating the enrollment process, we're here for you every step of the way.

Stay Connected

Receive marketing communications from PatientWing such as patient stories and relevant clinical trial opportunities.
By clicking subscribe, you consent to PatientWing contacting you in accordance with their Privacy Policy. You will be able to unsubscribe from PatientWing communications at any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Have Questions?

At PatientWing, we’re here to support you at every step of the study. You can email, text, call or fill out the form with any questions. We’re here to help.
Call Us
213-459-2979
Email Us
studies@patientwing.com
By clicking submit, you consent to sharing your personal data, including personal health information, with PatientWing and allowing PatientWing to collect this information and use it to contact you and respond as appropriate to your inquiry.  Please note that PatientWing will not sell your personal information or share it with third parties for marketing purposes.  For additional information on how PatientWing stores and processes personal data, please review their Privacy Policy. You will be able to unsubscribe from PatientWing communications and/or request that your information be deleted at any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tibulizumab is an investigational agent, meaning that its efficacy and safety have not been established by any regulatory agency worldwide.
A clinical study for people with systemic sclerosis.
Can I Participate?What To ExpectFrequently Asked QuestionsContact Us
© Copyright 2025 Powered by PatientWing
Privacy PolicyTerms & Conditions